{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:48Z","timestamp":1787020248239,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273265"],"award-info":[{"award-number":["82273265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Committee of Science and Technology","award":["GZY-ZJ-KJ-23029"],"award-info":[{"award-number":["GZY-ZJ-KJ-23029"]}]},{"name":"Major Project of Social Development of Jinhua Science and Technology Project","award":["2023-3-100"],"award-info":[{"award-number":["2023-3-100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12994-0","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:02:46Z","timestamp":1728446566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Cheng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huogang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangfa","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"17","key":"12994_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"1","key":"12994_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/codi.13124","volume":"18","author":"B Celerier","year":"2016","unstructured":"Celerier B, Denost Q, Van Geluwe B, Pontallier A, Rullier E. The risk of definitive stoma formation at 10 years after low and ultralow anterior resection for rectal cancer. Colorectal Dis. 2016;18(1):59\u201366.","journal-title":"Colorectal Dis"},{"issue":"10","key":"12994_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11894-020-00785-z","volume":"22","author":"TH Nguyen","year":"2020","unstructured":"Nguyen TH, Chokshi RV. Low anterior resection syndrome. Curr Gastroenterol Rep. 2020;22(10):48.","journal-title":"Curr Gastroenterol Rep"},{"key":"12994_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000437178","volume":"42","author":"JB Haanen","year":"2015","unstructured":"Haanen JB, Robert C. Immune Checkpoint inhibitors. Prog Tumor Res. 2015;42:55\u201366.","journal-title":"Prog Tumor Res"},{"issue":"1","key":"12994_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl L, Weng CH, Eghbali S, Wolchok JD, Merghoub T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat Rev Clin Oncol. 2022;19(1):37\u201350.","journal-title":"Nat Rev Clin Oncol"},{"issue":"25","key":"12994_CR6","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, El Dika IH, Segal N, Shcherba M, Sugarman R, et al. PD-1 blockade in Mismatch Repair-Deficient, locally advanced rectal Cancer. N Engl J Med. 2022;386(25):2363\u201376.","journal-title":"N Engl J Med"},{"issue":"13","key":"12994_CR7","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1158\/1078-0432.CCR-19-3728","volume":"26","author":"A Cercek","year":"2020","unstructured":"Cercek A, Dos Santos Fernandes G, Roxburgh CS, Ganesh K, Ng S, Sanchez-Vega F, Yaeger R, Segal NH, Reidy-Lagunes DL, Varghese AM, et al. Mismatch repair-deficient rectal Cancer and resistance to Neoadjuvant Chemotherapy. Clin Cancer Res. 2020;26(13):3271\u20139.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"12994_CR8","doi-asserted-by":"publisher","first-page":"188447","DOI":"10.1016\/j.bbcan.2020.188447","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188447.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"12994_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/1078-0432.CCR-21-3213","volume":"28","author":"H Bando","year":"2022","unstructured":"Bando H, Tsukada Y, Inamori K, Togashi Y, Koyama S, Kotani D, Fukuoka S, Yuki S, Komatsu Y, Homma S, et al. Preoperative chemoradiotherapy plus Nivolumab before surgery in patients with microsatellite stable and microsatellite instability-high locally advanced rectal Cancer. Clin Cancer Res. 2022;28(6):1136\u201346.","journal-title":"Clin Cancer Res"},{"key":"12994_CR10","doi-asserted-by":"crossref","unstructured":"Lin Z, Cai M, Zhang P, Li G, Liu T, Li X, Cai K, Nie X, Wang J, Liu J et al. Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer. J Immunother Cancer 2021, 9(11).","DOI":"10.1136\/jitc-2021-003554"},{"issue":"8","key":"12994_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ni957","volume":"4","author":"AA Itano","year":"2003","unstructured":"Itano AA, Jenkins MK. Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol. 2003;4(8):733\u20139.","journal-title":"Nat Immunol"},{"issue":"6","key":"12994_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345\u201359.","journal-title":"Nat Rev Cancer"},{"key":"12994_CR13","doi-asserted-by":"crossref","unstructured":"Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M, van Hall T, Ossendorp F. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight 2018, 3(23).","DOI":"10.1172\/jci.insight.124507"},{"issue":"6","key":"12994_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL, Tamaki SJ, Marquez DM, Tenvooren I, Wai K, et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023;186(6):1127\u2013e11431118.","journal-title":"Cell"},{"issue":"3","key":"12994_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, Yates KB, Lako A, Felt K, Naik GS, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20(3):326\u201336.","journal-title":"Nat Immunol"},{"issue":"3","key":"12994_CR16","doi-asserted-by":"publisher","first-page":"188704","DOI":"10.1016\/j.bbcan.2022.188704","volume":"1877","author":"MI Koukourakis","year":"2022","unstructured":"Koukourakis MI, Giatromanolaki A. Tumor draining lymph nodes, immune response, and radiotherapy: towards a revisal of therapeutic principles. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188704.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"12994_CR17","doi-asserted-by":"publisher","first-page":"109560","DOI":"10.1016\/j.biopha.2019.109560","volume":"121","author":"B Wang","year":"2020","unstructured":"Wang B, Wei J, Meng L, Wang H, Qu C, Chen X, Xin Y, Jiang X. Advances in pathogenic mechanisms and management of radiation-induced fibrosis. Biomed Pharmacother. 2020;121:109560.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"12994_CR18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/bjs.9811","volume":"102","author":"D Pettersson","year":"2015","unstructured":"Pettersson D, L\u00f6rinc E, Holm T, Iversen H, Cedermark B, Glimelius B, Martling A. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg. 2015;102(8):972\u20138. discussion 978.","journal-title":"Br J Surg"},{"issue":"1","key":"12994_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clcc.2021.10.001","volume":"21","author":"H Bando","year":"2022","unstructured":"Bando H, Tsukada Y, Ito M, Yoshino T. Novel immunological approaches in the treatment of locally advanced rectal Cancer. Clin Colorectal Cancer. 2022;21(1):3\u20139.","journal-title":"Clin Colorectal Cancer"},{"issue":"9","key":"12994_CR20","doi-asserted-by":"publisher","first-page":"e1555","DOI":"10.1002\/onco.13824","volume":"26","author":"S Liu","year":"2021","unstructured":"Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, Chen G, Xiao W. Total neoadjuvant therapy (TNT) versus standard Neoadjuvant Chemoradiotherapy for locally advanced rectal Cancer: a systematic review and Meta-analysis. Oncologist. 2021;26(9):e1555\u201366.","journal-title":"Oncologist"},{"issue":"7","key":"12994_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejso.2018.03.014","volume":"44","author":"S Hoendervangers","year":"2018","unstructured":"Hoendervangers S, Couwenberg AM, Intven MPW, van Grevenstein WMU, Verkooijen HM. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Eur J Surg Oncol. 2018;44(7):1013\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"12994_CR22","doi-asserted-by":"publisher","first-page":"1105180","DOI":"10.3389\/fimmu.2023.1105180","volume":"14","author":"J Shi","year":"2023","unstructured":"Shi J, Sun Z, Gao Z, Huang D, Hong H, Gu J. Radioimmunotherapy in colorectal cancer treatment: present and future. Front Immunol. 2023;14:1105180.","journal-title":"Front Immunol"},{"key":"12994_CR23","doi-asserted-by":"crossref","unstructured":"Seo I, Lee HW, Byun SJ, Park JY, Min H, Lee SH, Lee JS, Kim S, Bae SU. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer. J Immunother Cancer 2021, 9(3).","DOI":"10.1136\/jitc-2020-001610"},{"issue":"7","key":"12994_CR24","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-09-2982","volume":"70","author":"T Takeshima","year":"2010","unstructured":"Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, Shirato H, Kitamura H, Nishimura T. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 2010;70(7):2697\u2013706.","journal-title":"Cancer Res"},{"issue":"3","key":"12994_CR25","doi-asserted-by":"publisher","first-page":"e1395996","DOI":"10.1080\/2162402X.2017.1395996","volume":"7","author":"M Morisada","year":"2018","unstructured":"Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C, Hodge JW, Mitchell JB, Friedman J, Allen CT. PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation. Oncoimmunology. 2018;7(3):e1395996.","journal-title":"Oncoimmunology"},{"issue":"Suppl 4","key":"12994_CR26","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","volume":"29","author":"R Glynne-Jones","year":"2018","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263.","journal-title":"Ann Oncol"},{"key":"12994_CR27","doi-asserted-by":"crossref","unstructured":"Buchwald ZS, Nasti TH, Lee J, Eberhardt CS, Wieland A, Im SJ, Lawson D, Curran W, Ahmed R, Khan MK. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. J Immunother Cancer 2020, 8(2).","DOI":"10.1136\/jitc-2020-000867"},{"issue":"6","key":"12994_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s10147-013-0650-6","volume":"19","author":"J Chen","year":"2014","unstructured":"Chen J, Ou D, He X, Hu C. Sparing level ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. Int J Clin Oncol. 2014;19(6):998\u20131004.","journal-title":"Int J Clin Oncol"},{"issue":"11","key":"12994_CR29","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1093\/annonc\/mdt363","volume":"24","author":"D Tyc-Szczepaniak","year":"2013","unstructured":"Tyc-Szczepaniak D, Wyrwicz L, Kepka L, Michalski W, Olszyna-Serementa M, Palucki J, Pietrzak L, Rutkowski A, Bujko K. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study. Ann Oncol. 2013;24(11):2829\u201334.","journal-title":"Ann Oncol"},{"issue":"11","key":"12994_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/0284186X.2016.1177201","volume":"55","author":"D Tyc-Szczepaniak","year":"2016","unstructured":"Tyc-Szczepaniak D, Wyrwicz L, Wi\u015bniowska K, Michalski W, Pietrzak L, Bujko K. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a phase II study. Acta Oncol. 2016;55(11):1369\u201370.","journal-title":"Acta Oncol"},{"issue":"1","key":"12994_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13014-022-02031-4","volume":"17","author":"H Zhang","year":"2022","unstructured":"Zhang H, Li S, Jin X, Wu X, Zhang Z, Shen L, Wan J, Wang Y, Wang Y, Yang W, et al. Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer. Radiat Oncol. 2022;17(1):93.","journal-title":"Radiat Oncol"},{"issue":"59","key":"12994_CR32","doi-asserted-by":"publisher","first-page":"100746","DOI":"10.18632\/oncotarget.20602","volume":"8","author":"H Zhu","year":"2017","unstructured":"Zhu H, Bai B, Shan L, Wang X, Chen M, Mao W, Huang X. Preoperative radiotherapy for patients with rectal cancer: a risk factor for non-reversal of ileostomy caused by stenosis or stiffness proximal to colorectal anastomosis. Oncotarget. 2017;8(59):100746\u201353.","journal-title":"Oncotarget"},{"issue":"7","key":"12994_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/bjs\/znad113","volume":"110","author":"ME Verweij","year":"2023","unstructured":"Verweij ME, Franzen J, van Grevenstein WMU, Verkooijen HM, Intven MPW. Timing of rectal cancer surgery after short-course radiotherapy: national database study. Br J Surg. 2023;110(7):839\u201345.","journal-title":"Br J Surg"},{"issue":"2","key":"12994_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jamcollsurg.2018.03.034","volume":"227","author":"CL Sparreboom","year":"2018","unstructured":"Sparreboom CL, Wu Z, Lingsma HF, Menon AG, Kleinrensink GJ, Nuyttens JJ, Wouters MW, Lange JF. Anastomotic leakage and interval between Preoperative Short-Course Radiotherapy and Operation for rectal Cancer. J Am Coll Surg. 2018;227(2):223\u201331.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"12994_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"issue":"3","key":"12994_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","volume":"18","author":"J Erlandsson","year":"2017","unstructured":"Erlandsson J, Holm T, Pettersson D, Berglund \u00c5, Cedermark B, Radu C, Johansson H, Machado M, Hjern F, Hallb\u00f6\u00f6k O, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336\u201346.","journal-title":"Lancet Oncol"},{"key":"12994_CR37","doi-asserted-by":"publisher","first-page":"102104","DOI":"10.1016\/j.ctrv.2020.102104","volume":"90","author":"R Glynne-Jones","year":"2020","unstructured":"Glynne-Jones R, Hall M, Nagtegaal ID. The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 \u00d75 Gy) in rectal cancer - are we too eager for surgery? Cancer Treat Rev. 2020;90:102104.","journal-title":"Cancer Treat Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12994-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:03:04Z","timestamp":1728486184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12994-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12994"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12994-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3338014\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Sir Run Run Shao Hospital, Zhejiang University (Approval number: 2023\u2009\u2212\u20090386) and by the ethics review committees of all the participating centres. All participants were required to sign written informed consent before participating in the study. The identities of the participants will not be disclosed in any reports or publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1247"}}